ZA921005B - Imidazopyridine PAF/H 1 antagonists. - Google Patents

Imidazopyridine PAF/H 1 antagonists.

Info

Publication number
ZA921005B
ZA921005B ZA921005A ZA921005A ZA921005B ZA 921005 B ZA921005 B ZA 921005B ZA 921005 A ZA921005 A ZA 921005A ZA 921005 A ZA921005 A ZA 921005A ZA 921005 B ZA921005 B ZA 921005B
Authority
ZA
South Africa
Prior art keywords
pct
paf
antagonists
sec
imidazopyridine
Prior art date
Application number
ZA921005A
Other languages
English (en)
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA921005B publication Critical patent/ZA921005B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
ZA921005A 1991-02-13 1992-02-12 Imidazopyridine PAF/H 1 antagonists. ZA921005B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA921005B true ZA921005B (en) 1993-08-12

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921005A ZA921005B (en) 1991-02-13 1992-02-12 Imidazopyridine PAF/H 1 antagonists.

Country Status (29)

Country Link
US (1) US5358953A (OSRAM)
EP (1) EP0572425B1 (OSRAM)
JP (1) JP2506541B2 (OSRAM)
KR (1) KR970005302B1 (OSRAM)
CN (1) CN1040326C (OSRAM)
AT (1) ATE109482T1 (OSRAM)
AU (1) AU650322B2 (OSRAM)
BR (1) BR9205615A (OSRAM)
CA (1) CA2099381C (OSRAM)
CZ (1) CZ280504B6 (OSRAM)
DE (1) DE69200304T2 (OSRAM)
DK (1) DK0572425T3 (OSRAM)
EG (1) EG20085A (OSRAM)
ES (1) ES2059212T3 (OSRAM)
FI (1) FI933531A7 (OSRAM)
GB (1) GB9102997D0 (OSRAM)
HU (2) HUT65947A (OSRAM)
IE (1) IE65125B1 (OSRAM)
IL (1) IL100887A (OSRAM)
MX (1) MX9200589A (OSRAM)
MY (1) MY108437A (OSRAM)
NO (1) NO300592B1 (OSRAM)
NZ (1) NZ241597A (OSRAM)
PL (1) PL169304B1 (OSRAM)
RU (1) RU2114845C1 (OSRAM)
TW (1) TW227000B (OSRAM)
WO (1) WO1992014734A1 (OSRAM)
YU (1) YU48238B (OSRAM)
ZA (1) ZA921005B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5753671A (en) * 1994-08-10 1998-05-19 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (H1) and platelet activating factor (PAF) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
MX9707187A (es) * 1995-08-05 1997-11-29 British Biotech Pharm Derivados de imidazopiridina.
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
ES2572454T3 (es) 2003-05-15 2016-05-31 Ampio Pharmaceuticals Inc Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CA2713293A1 (en) 2008-01-30 2009-08-06 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-变态反应的苯并环庚并噻吩衍生物
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
AU2012323320B2 (en) 2011-10-10 2017-05-11 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2771007B1 (en) * 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
MX2015010937A (es) 2013-03-15 2015-10-29 Ampio Pharmaceuticals Inc Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas.
WO2016028790A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (OSRAM) * 1963-04-24
EP0404797B1 (en) * 1988-03-15 1995-02-01 G.D. Searle & Co. 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
CA1341370C (en) * 1988-04-28 2002-06-18 John J. Powinski Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
ATE112567T1 (de) * 1990-05-09 1994-10-15 Pfizer Imidazo(4,5-c>pyridine als paf antagonisten.

Also Published As

Publication number Publication date
PL169304B1 (pl) 1996-06-28
ATE109482T1 (de) 1994-08-15
JPH06504992A (ja) 1994-06-09
EG20085A (en) 1997-05-31
FI933531A0 (fi) 1993-08-10
MY108437A (en) 1996-09-30
GB9102997D0 (en) 1991-03-27
DE69200304D1 (de) 1994-09-08
AU650322B2 (en) 1994-06-16
IL100887A (en) 1996-01-19
KR970005302B1 (ko) 1997-04-15
YU48238B (sh) 1997-08-22
NO300592B1 (no) 1997-06-23
AU1168392A (en) 1992-09-15
WO1992014734A1 (en) 1992-09-03
NO932889D0 (no) 1993-08-13
FI933531L (fi) 1993-08-10
DE69200304T2 (de) 1994-12-08
IE920449A1 (en) 1992-08-12
NZ241597A (en) 1993-04-28
MX9200589A (es) 1992-10-01
HU9302327D0 (en) 1993-10-28
EP0572425B1 (en) 1994-08-03
US5358953A (en) 1994-10-25
HU211202A9 (en) 1995-11-28
FI933531A7 (fi) 1993-08-10
TW227000B (OSRAM) 1994-07-21
HUT65947A (en) 1994-08-29
YU14392A (sh) 1994-11-15
CN1040326C (zh) 1998-10-21
IL100887A0 (en) 1992-11-15
RU2114845C1 (ru) 1998-07-10
BR9205615A (pt) 1994-05-17
JP2506541B2 (ja) 1996-06-12
CA2099381A1 (en) 1992-08-14
CZ280504B6 (cs) 1996-02-14
EP0572425A1 (en) 1993-12-08
NO932889L (no) 1993-08-13
DK0572425T3 (da) 1994-09-12
CA2099381C (en) 1996-07-09
CN1064275A (zh) 1992-09-09
CS42592A3 (en) 1992-09-16
IE65125B1 (en) 1995-10-04
ES2059212T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
ZA921005B (en) Imidazopyridine PAF/H 1 antagonists.
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
HU9503930D0 (en) Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
SG164268A1 (en) Quinolin-4-yl derivatives i
DE69102762D1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
ATE62131T1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
PH17062A (en) Cephalosporins and pharmaceutical compositions
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
HU900728D0 (en) Process for preparation of calcium antagonistics
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PH15866A (en) Substituted 4-amino 2,6-diaryl-tetrahydrothiopyrans and salts thereof,and use as antidepressants
ES2084547B1 (es) Antagonistas benzopiranicos y relacionados de leucotrieno b4.
NL7609616A (en) (5)-Amino sulphonyl-benzene-(1,3)-dioxamic acids and esters - inhibitors of histamine release, useful e.g. in asthma treatment
ITMI920806A1 (it) Fontanile pluriuso
YU197091A (sh) Substituirani piperazinil kinoloni, postopki za njihovo pripravo in njihova uporaba